2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theEndometriosis Market from 2025 to 2034?

The endometriosis market is set to expand due to the rising prevalence of ovarian cancer. Originating in the ovaries – the female reproductive organs that generate eggs and hormones like estrogen and progesterone – ovarian cancer is increasingly being linked to endometriosis, a condition prevalent among individuals with high estrogen concentrations. Such individuals are at a higher risk of developing ovarian cancer, particularly the endometrioid and precise cell cancer subtypes. Predictions from the American Cancer Society suggest that nearly 19,710 women in the US will be diagnosed with ovarian cancer in the year 2023. Besides, data from the Ovarian Cancer Research Alliance – a nonprofit US organization – showed that ovarian cancer claimed 12,810 lives in 2022 with a subsequent rise to 13,270 deaths in 2023. Therefore, the escalating ovarian cancer rates are contributing to the expansion of the endometriosis market. Another significant stimulant for the endometriosis market is the surge in government funding. Non-government entities receiving full or partial financial aid from the government benefit from such funding. Research on endometriosis is often financially backed by government grants and contracts awarded to researchers and clinical research institutions. For instance, in March 2022, the U.S. federal government allotted $92 million to the National Institute of Child Health and Human Development (NICHD) and ensured the continuity of the $370 million funding for the Department of Defense’s Peer-Reviewed Medical Research Programme (PRMRP) aimed at promoting endometriosis research. Therefore, the ascension in government funding is fostering the growth of the endometriosis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp

#What is the Growth Potential of the Endometriosis Market, and How Will It Perform by 2034?

In recent years, the market size of endometriosis has witnessed swift expansion. It is projected to escalate from $1.4 billion in 2024 to $1.55 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. The significant growth within the past periods can be credited to factors such as delayed diagnosis and heightened awareness, sophistication in laparoscopic surgery, the progression of hormonal therapies, and the emergence of patient advocacy and support groups.

In the coming years, the endometriosis market is projected to experience robust growth. Estimated to reach $2.21 billion in 2029, it will have a compound annual growth rate (CAGR) of 9.3%. The anticipated growth during the forecast period is due to factors such as the introduction of minimally invasive procedures, advancements in pharmaceuticals, genetic and epigenetic research, and the worldwide expansion of women’s healthcare. During the forecast period, the key trends to watch include patient-focused care, precision medicine, virtual care, telemedicine, and the preservation of fertility.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13035

How Are Market Trends and Innovations Revolutionizing theEndometriosis Industry in Recent Times?

Key players in the endometriosis market are concentrating on the creation of innovative drugs like Myfembree and obtaining necessary approvals to offer novel treatments to patients. The debut of unique endometriosis medications caters to the previously unfulfilled need for effective remedies. For example, in August 2022, Swiss biopharmaceutical company Myovant Sciences GmbH and US pharmaceutical firm Pfizer Inc. secured U.S. Food and Drug Administration (FDA) approval for the use of Myfembree in treating moderate to severe endometriosis-related pain in premenopausal women. Myfembree, a once-a-day pill, is a blend of three key components: relugolix, estradiol, and norethindrone acetate, offering confirmed relief for premenopausal women with two disorders targeted by one pill. This presents an alternate treatment choice for women unable or disinclined to use hormone therapy.

Which Key Market Players Are Shaping the Future and Growth of theEndometriosis Market?

Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healthcare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healthcare Private Limited.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report

What Are the Core Segments of the Endometriosis Market, and How Do They Contribute to Growth?

The endometriosis market covered in this report is segmented –

1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types

2) By Treatment Type: Hormonal Therapy, Pain Management

3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs

4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:

1) By Superficial Peritoneal Lesion: Endometriotic Nodules, Peritoneal Endometriosis

2) By Endometrioma: Chocolate Cysts

3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis, Ureteral Endometriosis, Vaginal Endometriosis

4) By Other Types: Abdominal Endometriosis, Thoracic Endometriosis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13035&type=smp

What Regions Are Dominating the Endometriosis Market Growth?

North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Reports Similar to the Global Endometriosis Market 2025, By The Business Research Company:

Fertility Treatments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Fertility Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report

Fertility Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: